Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ViiV

UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment

The U.K.’s National Institute for Health and Care Excellence (NICE) is recommending a treatment from a firm jointly owned by GSK Plc (NYSE:GSK), Pfizer Inc (NYSE:PFE) and Shionogi Inc.

Benzinga · Oct 17, 2025

People with HIV offered hope of self-injected drug at home

GSK-controlled company works on developing patient-administered treatment by end of the decade

The Guardian - UK · Sep 28, 2023

The HIV prevention drug that could save millions of people – if they can afford it

CAB-LA injections offer stigma-free protection for those at risk – particularly women in Africa. A deal with pharmaceutical companies is crucial

The Guardian - UK · Aug 3, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Leading figures urge drugs firm to lower price of ‘game-changing’ HIV prevention drug

Signatories including Olly Alexander, Stephen Fry and Joseph Stiglitz issue a letter asking ViiV to make cabotegravir affordable to low- and middle-income countries

The Guardian - UK · Jul 21, 2022

Deborah Waterhouse: ‘The HIV stigma remains, and this is a battle we’ve got to fight’

The GSK executive has found her niche at ViiV Healthcare developing HIV drugs, and is optimistic a cure will be found

The Guardian - UK · Feb 5, 2022

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medicines Patent Pool

10 stories

National Institute for Health and Care Excellence

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.